Clinica Medicala Data Plus S.R.L.

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• COPD2 trials
• Heart failure2 trials
• Atrial fibrillation1 trial
• High blood pressure1 trial
• Type 2 diabetes1 trial

Phase

• Phase 36 trials

Status

• Recruiting3 trials
• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Boehringer Ingelheim3 trials
• Sanofi2 trials
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  NCT06424288· Phase 3· Boehringer Ingelheim· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure2 recruiting
• High blood pressure1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

  NCT06208306· Phase 3· Sanofi· Source

• Completed

  Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

  NCT04701983· Phase 3· Sanofi· Source